Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001704630 | SCV000570493 | likely benign | not provided | 2018-10-22 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000539550 | SCV000658068 | likely benign | Autosomal dominant nocturnal frontal lobe epilepsy | 2024-12-03 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV003352887 | SCV004078470 | uncertain significance | Inborn genetic diseases | 2023-06-23 | criteria provided, single submitter | clinical testing | The c.1376G>A (p.G459E) alteration is located in exon 5 (coding exon 5) of the CHRNA4 gene. This alteration results from a G to A substitution at nucleotide position 1376, causing the glycine (G) at amino acid position 459 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |